Description
VIP (vasoactive intestinal peptide) is a 28-amino-acid neuropeptide that signals through the VPAC1 and VPAC2 receptors, distributed widely across the nervous, cardiovascular and immune systems. It is a broadly acting messenger studied for vasodilation, smooth-muscle relaxation and immune regulation. (Supplier documentation is thin, so this draws on independent research.)
Mechanistic research describes VIP as activating VPAC receptors with anti-inflammatory and immune-regulatory effects across multiple tissues, examined in chronic-inflammatory-response and respiratory models. Genefyx supplies it as a research reference compound, mass-spec verified with a certificate of analysis, and it is not intended for human or animal use.
How it works
Agonist at VPAC1/VPAC2 receptors, with anti-inflammatory and immune-regulatory activity across multiple tissues.
Research context
Chronic-inflammatory-response and respiratory research.
Handling
Lyophilized powder. Certificate of analysis, ≥99% purity.
Research use only. Not for animal or human consumption. Not approved or evaluated by the FDA — not a drug, supplement, or therapy. Price shown is a placeholder pending final pricing.
Reviews
There are no reviews yet.